Review



cd8-pe clone sk1 antibody  (STEMCELL Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STEMCELL Technologies Inc cd8-pe clone sk1 antibody
    Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and <t>CD8+</t> T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.
    Cd8 Pe Clone Sk1 Antibody, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd8-pe clone sk1 antibody/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    cd8-pe clone sk1 antibody - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk"

    Article Title: Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0228633

    Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and CD8+ T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.
    Figure Legend Snippet: Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and CD8+ T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.

    Techniques Used:

    Pearson correlation (R) values between parameters. Colored boxes indicate significant (P <0.05) correlations.
    Figure Legend Snippet: Pearson correlation (R) values between parameters. Colored boxes indicate significant (P <0.05) correlations.

    Techniques Used:



    Similar Products

    antibody cd8 pe-cy7 clone sk1  (Thermo Fisher)
    90
    Thermo Fisher antibody cd8 pe-cy7 clone sk1
    ( a ) Exemplary flow cytometry density plots showing Fluorescence Minus One (FMO) control and CD4 stained cells in lymphocytes from healthy subjects and ischemic stroke patients. ( b ) Box and whiskers plot showing the percentage of CD4 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . ( c ) Representative density plots showing FMO control and <t>CD8</t> stained cells in lymphocytes from healthy subjects and ischemic stroke patients. ( d ) Graphical representation of flow cytometry data showing the percentage of CD8 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . Data are shown as the median, interquartile range and the minimum and maximum values.
    Antibody Cd8 Pe Cy7 Clone Sk1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody cd8 pe-cy7 clone sk1/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    antibody cd8 pe-cy7 clone sk1 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cd8-pe clone sk1 antibody  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc cd8-pe clone sk1 antibody
    Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and <t>CD8+</t> T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.
    Cd8 Pe Clone Sk1 Antibody, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd8-pe clone sk1 antibody/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    cd8-pe clone sk1 antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cd8-pe ( clone sk1) antibody  (Becton Dickinson)
    90
    Becton Dickinson cd8-pe ( clone sk1) antibody
    Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and <t>CD8+</t> T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.
    Cd8 Pe ( Clone Sk1) Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd8-pe ( clone sk1) antibody/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    cd8-pe ( clone sk1) antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    ifnγ-pe- and cd8-percp clone sk1-antibodies  (Becton Dickinson)
    90
    Becton Dickinson ifnγ-pe- and cd8-percp clone sk1-antibodies
    Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and <t>CD8+</t> T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.
    Ifnγ Pe And Cd8 Percp Clone Sk1 Antibodies, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ifnγ-pe- and cd8-percp clone sk1-antibodies/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    ifnγ-pe- and cd8-percp clone sk1-antibodies - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( a ) Exemplary flow cytometry density plots showing Fluorescence Minus One (FMO) control and CD4 stained cells in lymphocytes from healthy subjects and ischemic stroke patients. ( b ) Box and whiskers plot showing the percentage of CD4 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . ( c ) Representative density plots showing FMO control and CD8 stained cells in lymphocytes from healthy subjects and ischemic stroke patients. ( d ) Graphical representation of flow cytometry data showing the percentage of CD8 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . Data are shown as the median, interquartile range and the minimum and maximum values.

    Journal: Cells

    Article Title: Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes

    doi: 10.3390/cells9051072

    Figure Lengend Snippet: ( a ) Exemplary flow cytometry density plots showing Fluorescence Minus One (FMO) control and CD4 stained cells in lymphocytes from healthy subjects and ischemic stroke patients. ( b ) Box and whiskers plot showing the percentage of CD4 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . ( c ) Representative density plots showing FMO control and CD8 stained cells in lymphocytes from healthy subjects and ischemic stroke patients. ( d ) Graphical representation of flow cytometry data showing the percentage of CD8 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . Data are shown as the median, interquartile range and the minimum and maximum values.

    Article Snippet: Samples staining with directly conjugated antibodies for CD4 (PE-Cy5.5, clone SK3, eBioscience, San Diego, CA, USA), CD8 (PE-Cy7, clone SK1, eBioscience), CD39 (Alexa Fluor 488, clone A1, eBioscience) and CD73 (R-PE, clone AD2, eBioscience) was performed on 100 μl of each sample for 15 minutes, RT.

    Techniques: Flow Cytometry, Fluorescence, Control, Staining

    Sizes of different lymphocytic populations expressing CD39 and CD73 from healthy subjects (n = 20) and ischemic stroke patients (n = 21). Population size is given in the mean percentage ± SEM. Non-parametric two-tailed Mann–Whitney U-test was used to test for significance. * p <0.05; ** p < 0.01.

    Journal: Cells

    Article Title: Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes

    doi: 10.3390/cells9051072

    Figure Lengend Snippet: Sizes of different lymphocytic populations expressing CD39 and CD73 from healthy subjects (n = 20) and ischemic stroke patients (n = 21). Population size is given in the mean percentage ± SEM. Non-parametric two-tailed Mann–Whitney U-test was used to test for significance. * p <0.05; ** p < 0.01.

    Article Snippet: Samples staining with directly conjugated antibodies for CD4 (PE-Cy5.5, clone SK3, eBioscience, San Diego, CA, USA), CD8 (PE-Cy7, clone SK1, eBioscience), CD39 (Alexa Fluor 488, clone A1, eBioscience) and CD73 (R-PE, clone AD2, eBioscience) was performed on 100 μl of each sample for 15 minutes, RT.

    Techniques: Expressing, Mann-Whitney U-Test

    ( a ) Exemplary flow cytometry density plots showing FMO control and CD39 stained cells in CD8 + lymphocytes from healthy subjects and ischemic stroke patients. ( b ) Graphical representation of flow cytometry data showing the CD39 + percentage of CD8 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . ( c ) Representative density plots showing FMO control and CD73 stained cells in CD8 + lymphocytes from healthy subjects and ischemic stroke patients. ( d ) Box and Whiskers plot showing the proportion of CD73 + cells among CD8 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . Data are shown as the median, interquartile range and the minimum and maximum values. ** p < 0.01 vs healthy subjects.

    Journal: Cells

    Article Title: Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes

    doi: 10.3390/cells9051072

    Figure Lengend Snippet: ( a ) Exemplary flow cytometry density plots showing FMO control and CD39 stained cells in CD8 + lymphocytes from healthy subjects and ischemic stroke patients. ( b ) Graphical representation of flow cytometry data showing the CD39 + percentage of CD8 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . ( c ) Representative density plots showing FMO control and CD73 stained cells in CD8 + lymphocytes from healthy subjects and ischemic stroke patients. ( d ) Box and Whiskers plot showing the proportion of CD73 + cells among CD8 + lymphocytes in healthy subjects (n = 20) and ischemic stroke patients (n = 21) . Data are shown as the median, interquartile range and the minimum and maximum values. ** p < 0.01 vs healthy subjects.

    Article Snippet: Samples staining with directly conjugated antibodies for CD4 (PE-Cy5.5, clone SK3, eBioscience, San Diego, CA, USA), CD8 (PE-Cy7, clone SK1, eBioscience), CD39 (Alexa Fluor 488, clone A1, eBioscience) and CD73 (R-PE, clone AD2, eBioscience) was performed on 100 μl of each sample for 15 minutes, RT.

    Techniques: Flow Cytometry, Control, Staining

    Expression level of both CD39 and CD73 ectonucleotidases in lymphocytes from healthy subjects (n = 20) and ischemic stroke patients (n = 21). Data are reported as median fluorescence intensity (MFI) ± SEM. Non-parametric two-tailed Mann–Whitney U test was used to test for significance; ** p < 0.01.

    Journal: Cells

    Article Title: Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes

    doi: 10.3390/cells9051072

    Figure Lengend Snippet: Expression level of both CD39 and CD73 ectonucleotidases in lymphocytes from healthy subjects (n = 20) and ischemic stroke patients (n = 21). Data are reported as median fluorescence intensity (MFI) ± SEM. Non-parametric two-tailed Mann–Whitney U test was used to test for significance; ** p < 0.01.

    Article Snippet: Samples staining with directly conjugated antibodies for CD4 (PE-Cy5.5, clone SK3, eBioscience, San Diego, CA, USA), CD8 (PE-Cy7, clone SK1, eBioscience), CD39 (Alexa Fluor 488, clone A1, eBioscience) and CD73 (R-PE, clone AD2, eBioscience) was performed on 100 μl of each sample for 15 minutes, RT.

    Techniques: Expressing, Fluorescence, Mann-Whitney U-Test

    Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and CD8+ T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.

    Journal: PLoS ONE

    Article Title: Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk

    doi: 10.1371/journal.pone.0228633

    Figure Lengend Snippet: Volunteers with BMIs>35, each with a unique identifying symbol, were compared with controls for (A) CD4+ and CD8+ T cells and their CD4/CD8 ratio, (B) CD56/CD45, CD56 bright and dim NK cells and Tregs and (C) CD3 + CD28+ and CD3+ CD28– T cells. Each volunteer with a BMI>35 is identified with a unique symbol. Results are expressed as the mean ± SEM.

    Article Snippet: The antibodies used were: CD8-PE (clone SK1) and CD3-FITC (clone SK7) from StemCell Technologies, Vancouver, BC; CD45-FITC (Hle1), CD28-APC (clone CD28.2), CD4-PE-Cy7 (clone SK3), CD25-BB515 (clone 2A3), CD127-AF647 (clone HIL-7R-M21) and FoxP3-PE (clone 236A/E7) from BD Biosciences, Mississauga, ON; CD56-APC (clone CMSSB) from eBioscience, San Diego, CA.

    Techniques:

    Pearson correlation (R) values between parameters. Colored boxes indicate significant (P <0.05) correlations.

    Journal: PLoS ONE

    Article Title: Exploratory examination of inflammation state, immune response and blood cell composition in a human obese cohort to identify potential markers predicting cancer risk

    doi: 10.1371/journal.pone.0228633

    Figure Lengend Snippet: Pearson correlation (R) values between parameters. Colored boxes indicate significant (P <0.05) correlations.

    Article Snippet: The antibodies used were: CD8-PE (clone SK1) and CD3-FITC (clone SK7) from StemCell Technologies, Vancouver, BC; CD45-FITC (Hle1), CD28-APC (clone CD28.2), CD4-PE-Cy7 (clone SK3), CD25-BB515 (clone 2A3), CD127-AF647 (clone HIL-7R-M21) and FoxP3-PE (clone 236A/E7) from BD Biosciences, Mississauga, ON; CD56-APC (clone CMSSB) from eBioscience, San Diego, CA.

    Techniques: